Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

Upstart’s Breakout May Occur Sooner Than Expected – H2 2026 Macro Risks (NASDAQ:UPST)

1 September 2026

Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle (NYSE:AME)

1 September 2026

Top 25 Dividend Stock Opportunities For September 2026

1 September 2026

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

1 September 2026

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 1
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » Samsara Inc. (IOT) Q1 2027 Earnings Call Transcript
News

Samsara Inc. (IOT) Q1 2027 Earnings Call Transcript

thebusinesstimes.co.ukBy thebusinesstimes.co.uk5 June 20269 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Samsara Inc. (IOT) Q1 2027 Earnings Call Transcript
Share
Facebook Twitter LinkedIn Pinterest Email

Conference Call Participants

James Wood – TD Cowen, Research Division
Aleksandr Zukin – Wolfe Research, LLC
Christopher Quintero – Morgan Stanley, Research Division
Michael Turrin – Wells Fargo Securities, LLC, Research Division
James Fish – Piper Sandler & Co., Research Division
Matthew Hedberg – RBC Capital Markets, Research Division
Matthew Bullock – BofA Securities, Research Division
S. Kirk Materne – Evercore ISI Institutional Equities, Research Division
Jason Celino – KeyBanc Capital Markets Inc., Research Division
Daniel Jester – BMO Capital Markets Equity Research
Matthew Martino – Goldman Sachs Group, Inc., Research Division
Mark Schappel – Loop Capital Markets LLC, Research Division
Andrew DeGasperi – BNP Paribas, Research Division
Alexander Sklar – Raymond James & Associates, Inc., Research Division
Jackson Bogli – William Blair & Company L.L.C., Research Division
Isabella Camaj – JPMorgan Chase & Co, Research Division

Presentation

Mike Chang
Vice President of Corporate Development & Investor Relations

Good afternoon, and welcome to Samsara’s first quarter fiscal 2027 earnings call. I’m Mike Chang, Samsara’s senior vice president of finance. Joining me today are Samsara Chief Executive Officer and co-founder, Sanjit Biswas, and our Chief Financial Officer, Dominic Phillips. In addition to our prepared remarks on this call, additional information can be found in our shareholder letter, press release, investor presentation, and SEC filings on our investor relations website at investors.samsara.com. The measures we’ll discuss today include forward-looking statements. Actual results may differ materially from those contained in the forward-looking statements and are subject to risks and uncertainties described more fully in our SEC filings. Any forward-looking statements that we make on this call are based on assumptions as of today, June 4, 2026, and we undertake no obligation to update these statements as a result of new information or future events, unless required by law.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

Upstart’s Breakout May Occur Sooner Than Expected – H2 2026 Macro Risks (NASDAQ:UPST)

Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle (NYSE:AME)

Top 25 Dividend Stock Opportunities For September 2026

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

Pzena Focused Credit Opportunities Q2 2026 Commentary

Editors Picks

Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle (NYSE:AME)

1 September 2026

Top 25 Dividend Stock Opportunities For September 2026

1 September 2026

Cango Inc. (CANG) Q2 2026 Earnings Call Transcript

1 September 2026

Betmakers Technology Group Ltd (TPBTF) Q4 2026 Earnings Call Transcript

1 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

SPHB ETF: High Beta Means Strong Upside Capture But Weak Risk-Adjusted Returns;, Hold

1 September 2026

Shui On Land Limited 2026 Q2 – Results – Earnings Call Presentation (OTCMKTS:SOLLY) 2026-08-31

1 September 2026

Arrowhead Pharmaceuticals, Inc. (ARWR) Discusses SHASTA-3 and SHASTA-4 12-Month Results for Plozasiran in Severe Hypertriglyceridemia Transcript

31 August 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.